Changing perspective on immunization against influenza

This publication has 13 references indexed in Scilit:

• Host Range Restriction and Pathogenicity in the Context of Influenza Pandemic
  Emerging Infectious Diseases, 2006
• Dose‐Related Safety and Immunogenicity of a Trivalent Baculovirus‐Expressed Influenza‐Virus Hemagglutinin Vaccine in Elderly Adults
  The Journal of Infectious Diseases, 2006
• Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
  New England Journal of Medicine, 2006
• Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system
  Virology, 2005
• Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
  Vaccine, 2001
• Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
  The Journal of Pediatrics, 2000
• Preparation and characterization of a purified influenza virus neuraminidase vaccine
  Vaccine, 1995
• Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.
  Proceedings of the National Academy of Sciences, 1990
• Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.
  Proceedings of the National Academy of Sciences, 1987
• ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITAL
  The Lancet, 1979